Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) [Updated July 18, 2020] [open pdf - 372KB]
From the Document: "Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2]. Timely communication between clinical and laboratory sta is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided."
Centers for Disease Control and Prevention: https://www.cdc.gov/